Sucampo Pharmaceuticals, Inc.·5

Feb 13, 5:38 PM ET

Sucampo Pharmaceuticals, Inc. 5

5 · Sucampo Pharmaceuticals, Inc. · Filed Feb 13, 2015

Insider Transaction Report

Form 5
Period: 2014-12-31
Ueno Ryuji
DirectorCEO, Chief Scientific Officer10% Owner
Transactions
  • Gift

    Class A Common Stock

    2014-12-291,000,00021,460,802 total(indirect: By LLC)
Holdings
  • Class A Common Stock

    353,530
  • Class A Common Stock

    (indirect: By Spouse)
    60,357
Footnotes (2)
  • [F1]S&R Technology Holdings, LLC is wholly owned by Dr. Ueno and his wife. Dr. Ueno disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
  • [F2]Dr. Ueno disclaims beneficial ownership of the reported securities.

Documents

1 file
  • 5
    doc5.xmlPrimary

    FORM 5 SUBMISSION